Liver tumor removal or ablation study
Part of Cancer, Digestive system clinical trials.
This trial is studying people who have surgery or ablation (a procedure to destroy tumors) for liver growths, whether they are non-cancerous or cancerous. The goal is to gather information about these procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a liver growth that is either non-cancerous or cancerous.
- You are scheduled for or have had surgery to remove the growth or ablation to destroy it.
- You are not having a liver biopsy alone (just a sample taken) without any removal or destruction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who are having a procedure called thermal ablation to treat liver tumors. It aims to learn more about how well the procedure works and how safe it is.
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This study compares two nonsurgical procedures for liver cancer: stereotactic radiosurgery (focused radiation) and radiofrequency ablation (heat therapy). It is for people whose tumor is in a tricky spot near major blood vessels or other structures, making surgery difficult, and who have not received prior treatment.
This trial tests a needle-based device that uses heat or cold to destroy liver tumors. It is for people with primary or secondary liver cancer who cannot have surgery or a transplant.
This study collects information from people having liver surgery for a non-cancerous tumor or for liver cancer (primary or cancer that spread to the liver). It doesn’t usually add treatment—your care is documented to help doctors learn and improve future decisions.
Hear when a new Benign Liver Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.